AI-Powered Genotype Predictor from H&E
Research Use Only. Not for use in diagnostic procedures
Rapid AI-powered prediction of tumor genotype from H&E
Request More InfoBenefits
Clinical Trials
Quickly pre-screen patients
for clinical trial enrollment
Drug Development
Develop novel AI signatures from H&E to
predict therapy response and resistance
Lunit Announces Collaboration with AstraZeneca to Develop
AI-Powered Digital Pathology Risk Assessment Tools for NSCLC
READ MOREBased on H&E slide analysis,
Lunit SCOPE GP offers insights into tumor
genomics and molecular characteristics
Genomic Aberration
Genomic Signatures
Key Features
Lunit SCOPE GP is developed with multiple methods in
a novel way to improve performance
Combining Unsupervised + Supervised Learning to improve predictive power
FOUNDATION MODEL-BASED
FEATURE EXTRACTION
(Self-supervised Learning)
ACTUAL BIOLOGICAL
FEATURE EXTRACTION
(Supervised Learning)
We can build and fine-tune
models according to your needs
Quick Development
Performance tests within weeks,
based on the core model
